Compound Detail
CHEMBL41291
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL41291 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | UGPKILZIIJMWGQ-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
364.8
MW (Da)
5.15
ALogP
5
HBA
2
HBD
75.5
PSA (Ų)
0.53
QED
1
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 6.96
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Glutamate [NMDA] receptor CHEMBL2094124 | IC50 | 6.96 | 6.96 | 110.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Glutamate [NMDA] receptor | IC50 | = | 110.0 | nM | 6.96 | Inhibition of [3H]DCKA binding to N-methyl-D-aspartate glutamate receptor | 12699379 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 12699379 | 10.1021/jm0210156 | Glutamate [NMDA] receptor | 2 |
Data from ChEMBL 36 via Core Engine